The circular will come into effect from May 1, 2026, and will apply to all content uploaded on or after that date ...
Doxorubicin is one of the most potent antitumor agents available; however, its clinical use is restricted because it poses a risk of severe cardiotoxicity. Previous work has established that CircITCH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results